Literature DB >> 9400741

Expression of inducible nitric oxide synthase and formation of nitric oxide by alveolar macrophages: an interspecies comparison.

N K Jesch1, M Dörger, G Enders, G Rieder, C Vogelmeier, K Messmer, F Krombach.   

Abstract

Nitric oxide (NO) is suggested to play a role in mediating pulmonary injury. However, interspecies differences appear to exist in the ability of alveolar macrophages (AM) to express the inducible nitric oxide synthase (iNOS) and to generate NO. The purpose of this study was to compare iNOS expression and NO production by rat, hamster, monkey, and human AM using the identical experimental conditions in vitro. As AM donors, CD rats, Syrian golden hamsters, cynomolgus monkeys, and nonsmoking, healthy human volunteers were used. The AM were obtained by bronchoalveolar lavage and stimulated in vitro with various concentrations and combinations of lipopolysaccharide (LPS) and interferon-gamma (IFN-gamma). The oxidation product of NO, nitrite, was measured in the AM supernatant by the Griess reaction. The expression of iNOS in AM was detected using immunocytochemistry and immunoblotting. The expression of iNOS mRNA was assessed by reverse transcriptase-polymerase chain reaction (RT-PCR). Rat AM, stimulated with either LPS or IFN-gamma, produced nitrite in a time- and dose-dependent manner. Combination of LPS and IFN-gamma resulted in a significantly enhanced nitrite formation. However, none of the treatments was able to induce hamster, monkey, or human AM to release measurable amounts of nitrite. Whereas expression of iNOS protein was only detected in stimulated rat AM, expression of iNOS mRNA was found in unstimulated and stimulated rat AM, slightly in stimulated hamster AM, but not in monkey and human AM. In conclusion, our findings point to distinct regulatory mechanisms of the NO pathway in AM from these four different species.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9400741      PMCID: PMC1470164          DOI: 10.1289/ehp.97105s51297

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  25 in total

1.  Tumours of the respiratory tract in rats and hamsters following chronic inhalation of engine exhaust emissions.

Authors:  J Brightwell; X Fouillet; A L Cassano-Zoppi; D Bernstein; F Crawley; F Duchosal; R Gatz; S Perczel; H Pfeifer
Journal:  J Appl Toxicol       Date:  1989-02       Impact factor: 3.446

2.  Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate.

Authors:  M L Cameron; D L Granger; J B Weinberg; W J Kozumbo; H S Koren
Journal:  Am Rev Respir Dis       Date:  1990-12

3.  Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes.

Authors:  M Schneemann; G Schoedon; S Hofer; N Blau; L Guerrero; A Schaffner
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

4.  Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA.

Authors:  S Liu; I M Adcock; R W Old; P J Barnes; T W Evans
Journal:  Biochem Biophys Res Commun       Date:  1993-11-15       Impact factor: 3.575

5.  Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization.

Authors:  L Kobzik; D S Bredt; C J Lowenstein; J Drazen; B Gaston; D Sugarbaker; J S Stamler
Journal:  Am J Respir Cell Mol Biol       Date:  1993-10       Impact factor: 6.914

6.  Species variation in lung antioxidant enzyme activities.

Authors:  C L Bryan; S G Jenkinson
Journal:  J Appl Physiol (1985)       Date:  1987-08

7.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

Authors:  A H Ding; C F Nathan; D J Stuehr
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

8.  Enhanced production of nitric oxide by rat alveolar macrophages after inhalation of a pulmonary irritant is associated with increased expression of nitric oxide synthase.

Authors:  K J Pendino; J D Laskin; R L Shuler; C J Punjabi; D L Laskin
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

9.  Peroxynitrite formation from macrophage-derived nitric oxide.

Authors:  H Ischiropoulos; L Zhu; J S Beckman
Journal:  Arch Biochem Biophys       Date:  1992-11-01       Impact factor: 4.013

10.  Evaluation of nitrite production by human monocyte-derived macrophages.

Authors:  E L Padgett; S B Pruett
Journal:  Biochem Biophys Res Commun       Date:  1992-07-31       Impact factor: 3.575

View more
  16 in total

1.  Potent immunoregulatory effects of Salmonella typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells.

Authors:  T L Wyant; M K Tanner; M B Sztein
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

2.  Expression of inducible nitric oxide synthase mRNA and nitric oxide production during the development of liver abscess in hamster inoculated with Entamoeba histolytica.

Authors:  Joel Ramírez-Emiliano; Angélica González-Hernández; Sergio Arias-Negrete
Journal:  Curr Microbiol       Date:  2005-06-13       Impact factor: 2.188

Review 3.  Alveolar macrophages in pulmonary host defence the unrecognized role of apoptosis as a mechanism of intracellular bacterial killing.

Authors:  J D Aberdein; J Cole; M A Bewley; H M Marriott; D H Dockrell
Journal:  Clin Exp Immunol       Date:  2013-11       Impact factor: 4.330

4.  Impaired response to interferon-gamma in activated macrophages due to tyrosine nitration of STAT1 by endogenous nitric oxide.

Authors:  M Llovera; J D Pearson; C Moreno; V Riveros-Moreno
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

5.  Quantitative aspects of lipopolysaccharide and cytokine requirements to generate nitric oxide in macrophages from LPS-hyporesponsive (Lps(d)) C3H/HeJ mice.

Authors:  E Kmonícková; Z Zídek
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

6.  Identification of hamster inducible nitric oxide synthase (iNOS) promoter sequences that influence basal and inducible iNOS expression.

Authors:  Omar A Saldarriaga; Bruno L Travi; Goutam Ghosh Choudhury; Peter C Melby
Journal:  J Leukoc Biol       Date:  2012-04-18       Impact factor: 4.962

7.  The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A.

Authors:  Philip O'Reilly; Judy M Hickman-Davis; Philip McArdle; K Randall Young; Sadis Matalon
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

8.  Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages.

Authors:  Kate Schroder; Katharine M Irvine; Martin S Taylor; Nilesh J Bokil; Kim-Anh Le Cao; Kelly-Anne Masterman; Larisa I Labzin; Colin A Semple; Ronan Kapetanovic; Lynsey Fairbairn; Altuna Akalin; Geoffrey J Faulkner; John Kenneth Baillie; Milena Gongora; Carsten O Daub; Hideya Kawaji; Geoffrey J McLachlan; Nick Goldman; Sean M Grimmond; Piero Carninci; Harukazu Suzuki; Yoshihide Hayashizaki; Boris Lenhard; David A Hume; Matthew J Sweet
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

9.  Alveolar Macrophage Apoptosis-associated Bacterial Killing Helps Prevent Murine Pneumonia.

Authors:  Julie A Preston; Martin A Bewley; Helen M Marriott; A McGarry Houghton; Mohammed Mohasin; Jamil Jubrail; Lucy Morris; Yvonne L Stephenson; Simon Cross; David R Greaves; Ruth W Craig; Nico van Rooijen; Colin D Bingle; Robert C Read; Timothy J Mitchell; Moira K B Whyte; Steven D Shapiro; David H Dockrell
Journal:  Am J Respir Crit Care Med       Date:  2019-07-01       Impact factor: 21.405

10.  Production of proinflammatory mediators by indoor air bacteria and fungal spores in mouse and human cell lines.

Authors:  Kati Huttunen; Anne Hyvärinen; Aino Nevalainen; Hannu Komulainen; Maija-Riitta Hirvonen
Journal:  Environ Health Perspect       Date:  2003-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.